Retrospective Cohort Study of Beta‑Lactam Treatment for Ampc‑Overexpressing Enterobacteriaceae in a French Intensive Care Unit: Clinical Outcomes and Associated Factors

ABSTRACT Introduction. Infections caused by group 3 Enterobacteriaceae overexpressing AmpC beta-lactamase (EB3-AmpC+) represent a major therapeutic challenge in intensive care. This study aimed to evaluate treatment and 28-day mortality in intensive care patients treated with beta-lactams for EB3-...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kossi Odjo Dogbe YZ, Boulama Mahamadou MB, Soumana Diaouga H, Bachar Loukoumi O, Amadou Hamadou S, Daddy H, Chaibou MS
Format:	Artigo
Idioma:	Inglês
Publicat:	Afrimvoe Medical Services, Yaounde (Cameroon) 2026-05-01
Col·lecció:	Health Research in Africa
Matèries:	AmpC Beta-lactamase Enterobacterales Beta-lactams ICU Clinical failure
Accés en línia:	https://ams-hra.org/index.php/hra/article/view/7815
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!